SENISCA

We're delighted to be participating in the upcoming RNA Therapeutics Conference at UMass. SENISCA's Co-founder and CSO, Lorna Harries, will be presenting on Friday 28th June - please come and say hello! https://lnkd.in/ddn_5Jr

Excited to announce that SENISCA's CSO, Lorna Harries, will be giving the opening presentation at the BIRA conference tomorrow. Lorna will be delighted to chat further so please come and say hello! https://lnkd.in/e8eA3a2u

SENISCA CEO Sarah Cole is at Bio€quity Europe 2024 https://lnkd.in/dzunkQc, in San Sebastián. Come and hear her speak at 14:30 on Monday 13th, as part of the Nucleic Acid Therapeutics Track. BioCentury Inc.

SENISCA co-founder and Chief Scientific Officer, Lorna Harries, is at Forever Healthy's Rejuvenation Startup Summit 2024, in Berlin. Come and hear her speak about SENISCA's work at 4.30pm, May 10th: https://lnkd.in/ehZM-Nty

We’re out at conferences this week. Come and say hello and find out more about SENISCA’s work. Our Chief Scientific Officer Lorna Harries is at https://swissbiotechday.ch on the 22nd and 23rd. She is presenting about SENISCA’s work at 9am on the 23rd: https://lnkd.in/d7dCGSub Our CEO Sarah Cole and Chief Development Officer Tim Sebastian Schmidt are at https://lnkd.in/dmBez3G2 on the 23rd and 24th. Sarah is presenting in Science Track 2 at 10am on the 23rd: https://lnkd.in/e8DS6A-G

Exciting times! We’re #hiring a new Head of Intellectual Property in Exeter, England. Apply today or share this post with your network.

👏 University of Exeter spin-out and SETsquared Exeter member, SENISCA has secured £3.7m investment to support the rapid development of its senotherapeutic platform to treat age-related diseases. The former Scale-Up Programme member has developed a proprietary technology that harnesses RNA biology to reprogramme aged ‘senescent’ cells – a variation which behaves differently to their younger and healthier counterparts. These cells, often present in ageing tissues and organs with a pro-inflammatory profile and disrupted function are emerging as factors present within age-related diseases. Get the full story 👉 https://ow.ly/IqlB50QWOz3 #MedTech #Investment #Funding

SENISCA COO Kirsty Semple joins the panel with Ben Cooper, Anna W., Patric Eriksson and Jon Bonnick to discuss Unleashing the South West's Investment Potential at the South West Investment Summit today. https://lnkd.in/dt4u9TYb

SENISCA is delighted to be participating in BIO-Europe Spring, 18-20th March. If you would like to hear more about the company as it continues to rapidly evolve, our CEO Dr Sarah Cole will be presenting at 14.45pm today (18th March). Sarah will be delighted to chat further, so please feel free to come and say hello.  https://lnkd.in/dtz6sQFr

We’re pleased to announce that we’ve raised £3.7 million in our latest seed funding round. Thanks to all our investors, existing and new, including Emerging Longevity Ventures, QantX, the R42 Group, Trend Investment Group, APEX Ventures and Lifespan Vision Ventures. Read more here: https://lnkd.in/eGw-YMRY